Skip Ribbon Commands
Skip to main content

​​Non-alcoholic Fatty Liver Disease or NAFLD

The Spectrum of NAFLD: Elevated Liver Tests, Cirrhosis and Liver Cancer Estimates show that 20 to 30 percent of the U.S. population has non-alcoholic fatty liver disease or NAFLD. NAFLD is a broad term used to describe a spectrum of liver diseases with evidence of steatosis (or fat) in the liver once other causes of […]

READ MORE


New Hepatitis C Drugs, Sofosbuvir and Simeprevir

Newly Approved Drugs Show High Cure Rates for Hepatitis C Two new drugs are providing hope to the approximately 3.2 million people in the United States who are infected with the hepatitis C virus. Unlike the previous therapy, the new drugs have minimal side effects and offer most patients an almost 90 percent chance at […]

READ MORE


Hepatic Elastography and Liver Disease

MR-based hepatic elastography involves mechanical stimulation of the liver to determine liver stiffness, which can be used as an index for how much fibrosis is present. Baylor University Medical Center at Dallas is one of the few medical centers in the nation to offer this advanced imaging technology.

READ MORE


Transplant Hepatology Fellowship Program

The liver transplant program at the Annette C. and Harold C. Transplant Institute at Baylor University Medical Center at Dallas and Baylor All Saints Medical Center at Fort Worth is the fifth largest in the United States. More than 100 liver transplants are performed annually. The surgical team is lead by Dr. Goran Klintmalm and […]

READ MORE


Hepatitis C, a Silent Killer, Meets Its Match

New York Times, November 4, 2013 Medicine may be on the brink of an enormous public health achievement: turning the tide against hepatitis C, a silent plague that kills more Americans annually than AIDS and is the leading cause of liver transplants. If the effort succeeds, it will be an unusual conquest of a viral […]

READ MORE


New Hepatitis C Treatment

There are 3 million Americans infected with Hepatitis C, and three out of four of them are baby boomers. Most of them contracted the disease without knowing it. But there is a new treatment that was just approved by the FDA. Dr. Jacqueline O’Leary discusses in the video below.

READ MORE


Clinical Studies

Our team of hepatologists play an integral role in the development of select clinical studies of approved antiviral medications to treat hepatitis C and hepatitis B. More than 40 drug trials designed to treat or cure the hepatitis C virus are currently underway at Baylor Dallas and Baylor Fort Worth. For more information regarding clinical […]

READ MORE


Incidence of Liver Disease Underestimated

According to the National Center for Health Statistics (NCHS), chronic liver disease and cirrhosis is the 12(th) leading cause of death in the United States. However, this single descriptor might not adequately enumerate all deaths from liver disease. The aim of our study was to update data on liver mortality in the United States. Read […]

READ MORE